Luxembourg-based venture capital firm Catalpa Ventures has secured €10 million in commitments from its €30 million Catalpa Health Fund I. Backers include entrepreneurs, family offices, and industry leaders, with a final close targeted for the first quarter of 2027.
- Founded in 2024 by Dr. Thomas Goergen, Prof. Silke R. Sperling, and Dr. Christian Goergen, Catalpa Ventures invests in early-stage healthtech startups across Europe. The firm focuses on digital tools, disease prevention technologies, and workflow solutions for clinics, laboratories, and healthcare providers.
- Catalpa Health Fund I aims to make 15–20 investments over four years, with ticket sizes of €300,000 to €1.5 million and follow-on funding for high-performing companies.
- The fund prioritizes European founders and technologies that improve disease prevention and management, support healthcare professionals, or reduce administrative burdens across clinical and research settings.
“We are building a platform for bold innovation and real impact, backing tomorrow’s HealthTech leaders to transform care for millions,” claims Dr Thomas Goergen, Partner at Catalpa Ventures.
- Its first investment was in Noah Labs, a telemedicine platform for heart failure management using voice analytics to improve care and reduce hospitalizations, recently secured €1.9 million in new funding.
